rs200137341

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_020822.3(KCNT1):​c.146C>G​(p.Thr49Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000058 in 1,447,724 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. T49T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000040 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000060 ( 0 hom. )

Consequence

KCNT1
NM_020822.3 missense

Scores

2
14

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.76

Publications

0 publications found
Variant links:
Genes affected
KCNT1 (HGNC:18865): (potassium sodium-activated channel subfamily T member 1) Potassium channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a sodium-activated potassium channel subunit which is thought to function in ion conductance and developmental signaling pathways. Mutations in this gene cause the early-onset epileptic disorders, malignant migrating partial seizures of infancy and autosomal dominant nocturnal frontal lobe epilepsy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2012]
KCNT1 Gene-Disease associations (from GenCC):
  • childhood-onset epilepsy syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 14
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • malignant migrating partial seizures of infancy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • autosomal dominant nocturnal frontal lobe epilepsy 5
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nocturnal frontal lobe epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0130446255).
BP6
Variant 9-135714612-C-G is Benign according to our data. Variant chr9-135714612-C-G is described in ClinVar as Likely_benign. ClinVar VariationId is 386452.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 6 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020822.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNT1
NM_020822.3
MANE Select
c.146C>Gp.Thr49Ser
missense
Exon 2 of 31NP_065873.2Q5JUK3-3
KCNT1
NM_001272003.2
c.110+12244C>G
intron
N/ANP_001258932.1Q5JUK3-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNT1
ENST00000371757.7
TSL:1 MANE Select
c.146C>Gp.Thr49Ser
missense
Exon 2 of 31ENSP00000360822.2Q5JUK3-3
KCNT1
ENST00000460750.5
TSL:1
n.146C>G
non_coding_transcript_exon
Exon 2 of 32ENSP00000418777.1F8WC49
KCNT1
ENST00000487664.5
TSL:5
c.146C>Gp.Thr49Ser
missense
Exon 2 of 32ENSP00000417851.2Q5JUK3-2

Frequencies

GnomAD3 genomes
AF:
0.0000400
AC:
6
AN:
149844
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000663
Gnomad ASJ
AF:
0.00116
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000149
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000150
AC:
26
AN:
173776
AF XY:
0.000173
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00297
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000254
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000601
AC:
78
AN:
1297880
Hom.:
0
Cov.:
30
AF XY:
0.0000650
AC XY:
42
AN XY:
645764
show subpopulations
African (AFR)
AF:
0.000308
AC:
8
AN:
25938
American (AMR)
AF:
0.0000600
AC:
2
AN:
33342
Ashkenazi Jewish (ASJ)
AF:
0.00220
AC:
45
AN:
20500
East Asian (EAS)
AF:
0.00
AC:
0
AN:
26050
South Asian (SAS)
AF:
0.00
AC:
0
AN:
75168
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
42080
Middle Eastern (MID)
AF:
0.000236
AC:
1
AN:
4242
European-Non Finnish (NFE)
AF:
0.0000147
AC:
15
AN:
1020458
Other (OTH)
AF:
0.000140
AC:
7
AN:
50102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
5
11
16
22
27
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000400
AC:
6
AN:
149844
Hom.:
0
Cov.:
32
AF XY:
0.0000410
AC XY:
3
AN XY:
73084
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41192
American (AMR)
AF:
0.0000663
AC:
1
AN:
15076
Ashkenazi Jewish (ASJ)
AF:
0.00116
AC:
4
AN:
3434
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5150
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9696
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.0000149
AC:
1
AN:
67186
Other (OTH)
AF:
0.00
AC:
0
AN:
2056
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.442
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000653
Hom.:
0
ExAC
AF:
0.0000928
AC:
11

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not specified (2)
-
-
1
Autosomal dominant nocturnal frontal lobe epilepsy 5 (1)
-
-
1
Developmental and epileptic encephalopathy, 14 (1)
-
-
1
Developmental and epileptic encephalopathy, 14;C3554306:Autosomal dominant nocturnal frontal lobe epilepsy 5 (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.095
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.74
CADD
Benign
13
DANN
Benign
0.91
Eigen
Benign
-0.77
Eigen_PC
Benign
-0.68
FATHMM_MKL
Benign
0.19
N
LIST_S2
Benign
0.32
T
M_CAP
Uncertain
0.12
D
MetaRNN
Benign
0.013
T
MetaSVM
Benign
-0.99
T
PhyloP100
1.8
PrimateAI
Uncertain
0.74
T
PROVEAN
Benign
-0.20
N
REVEL
Benign
0.078
Sift
Benign
0.085
T
Sift4G
Benign
0.10
T
Vest4
0.066
MutPred
0.24
Gain of disorder (P = 0.055)
MVP
0.15
MPC
0.57
ClinPred
0.12
T
GERP RS
1.3
PromoterAI
-0.074
Neutral
gMVP
0.13
Mutation Taster
=86/14
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200137341; hg19: chr9-138606458; API